Pharm Mod B

Edit Answers
12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152
Across
  1. 1. long acting anticholinergic reducing COPD symptoms
  2. 10. handheld inhaler delivering measured dose per puff
  3. 13. alternative SABA with fewer side effects
  4. 15. continuous bronchial inflammation with mucus hypersecretion
  5. 17. inhaled steroid reducing airway hyperreactivity
  6. 19. severe asthma attack unresponsive to usual therapy
  7. 24. short acting beta agonists for acute bronchospasm
  8. 26. expectorant increasing secretion flow for productive cough
  9. 27. chronic inflammatory airway disorder with bronchoconstriction and mucus production
  10. 28. anti inflammatory drugs blocking leukotriene receptors
  11. 32. oral or IV steroids for severe asthma or COPD exacerbations
  12. 33. inhaled steroid for long term asthma control
  13. 38. long acting bronchodilator for maintenance
  14. 39. oral systemic glucocorticoid for acute exacerbations
  15. 40. steroid spray reducing nasal inflammation
  16. 43. reduce nasal swelling via alpha adrenergic stimulation
  17. 44. assesses asthma control and airway caliber
  18. 46. xanthine drug with narrow therapeutic index
  19. 47. long acting beta agonists for maintenance therapy not for acute attacks
  20. 48. LABA used only with inhaled corticosteroids
  21. 49. chronic progressive airflow limitation with inflammation
  22. 50. long acting anticholinergic for COPD maintenance
  23. 51. suppress nonproductive cough
  24. 52. non opioid antitussive suppressing cough reflex
Down
  1. 2. inhaled anticholinergic improving airflow in COPD
  2. 3. bronchodilators relaxing airway smooth muscle
  3. 4. common SABA for rapid relief of bronchospasm
  4. 5. first line anti inflammatory drugs for persistent asthma
  5. 6. oral decongestant reducing nasal congestion
  6. 7. IV systemic steroid for severe respiratory distress
  7. 8. bronchodilators activating beta2 receptors to relieve bronchospasm
  8. 9. antihistamine with low sedation risk
  9. 11. alveolar wall destruction reducing gas exchange surface
  10. 12. first generation antihistamine causing sedation
  11. 14. leukotriene synthesis inhibitor reducing inflammation
  12. 16. mucolytic thinning mucus and aiding clearance
  13. 18. steroid inhaler complication requiring rinse and spit
  14. 20. bronchodilators blocking muscarinic receptors to reduce bronchoconstriction
  15. 21. leukotriene inhibitor with black box warning for neuropsychiatric events
  16. 22. deliver medication directly to lungs with fewer systemic effects
  17. 23. IV xanthine for status asthmaticus not responding to SABA
  18. 25. block histamine receptors to reduce allergy symptoms
  19. 29. device delivering powdered medication by inhalation
  20. 30. nasal decongestant with rebound congestion risk
  21. 31. inhaled steroid decreasing airway inflammation
  22. 34. device producing fine mist for inhalation therapy
  23. 35. leukotriene receptor blocker improving asthma control
  24. 36. most effective therapy for allergic rhinitis
  25. 37. inhaled glucocorticoid reducing airway inflammation
  26. 41. antitussive anesthetizing stretch receptors in respiratory tract
  27. 42. non sedating antihistamine for allergic rhinitis
  28. 45. second generation antihistamine with minimal sedation